Sun Pharmaceutical Industries has received US Food and Drugs Administration’s (USFDA) approval for a painkiller tablet called ‘Oxymorphone Hydrochloride’. Including this medicine, the company has received total seven approvals from US FDA in last one year, these medicine are- Oxymorphone Hydrochloride, Fesoterodine Fumarate, Opcicon One-step, Clonazepam, Clonidine Hydrochloride, Hydrochlorothiazide and Furosemide.
Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1882.00 |
| Dr. Reddys Labs. | 1345.00 |
| Cipla | 1433.85 |
| Zydus Lifesciences | 1156.65 |
| Lupin | 2471.90 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: